Table 1 Demographic data and preexisting comorbidities in 239 critically ill patients with COVID-19
Characteristics | All patients (n = 239) | Non-survivors (n = 147) | Survivors (n = 92) | p value, survivors vs non-survivors |
|---|---|---|---|---|
Age, mean ± SD, years | 62.5 ± 13.3 | 65.7 ± 12.2 | 57.5 ± 13.5 | < 0.001 |
Age ≥ 65 years | 112 (46.9%) | 82 (55.8%) | 30 (32.6%) | < 0.001 |
Male | 143 (59.8%) | 90 (61.2%) | 53 (57.6%) | 0.337 |
APACHE II, median [IQR]a | 15 [13–17] | 15 [13–17] | 13 [11–15] | 0.006 |
SOFA scorea | 6 [5–7] | 6 [5–7] | 5 [5–6] | 0.0163 |
Preexisting comorbidities | ||||
Hypertension | 105 (43.9%) | 64 (43.5%) | 41 (44.6%) | 0.491 |
Chronic cardiac disease | 35 (14.6%) | 21 (14.3%) | 14 (15.2%) | 0.492 |
Chronic pulmonary disease | 12 (5.0%) | 9 (6.1%) | 3 (3.3%) | 0.253 |
Cerebrovascular disease | 13 (5.4%) | 9 (6.1%) | 4 (4.3%) | 0.392 |
Chronic liver disease | 20 (8.4%) | 13 (9.4%) | 7 (8.4%) | 0.511 |
Malignancy | 13 (5.4%) | 11 (7.5%) | 2 (2.2%) | 0.066 |
Diabetes | 44 (18.4%) | 24 (17.7%) | 18 (19.6%) | 0.420 |